Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-094093
Filing Date
2025-07-03
Accepted
2025-07-03 19:04:53
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5423
  Complete submission text file 0000950170-25-094093.txt   6978
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SOLID BIOSCIENCES, LLC 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address
Sullivan Lynne Marie (Reporting) CIK: 0001727640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 251106728